Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Becton Dickinson (NY: BDX )

225.45 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Becton Dickinson

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
BD Scores FDA Clearance For Artificial Intelligence Software To Interpret Bacterial Growth
Via Benzinga
Becton, Dickinson's Return On Capital Employed Overview
Via Benzinga
$1000 Invested In This Stock 20 Years Ago Would Be Worth $6,900 Today
Via Benzinga
Where Becton, Dickinson Stands With Analysts
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 5, 2023
Via Benzinga
Here's How Much $100 Invested In Becton, Dickinson 10 Years Ago Would Be Worth Today
Via Benzinga
The Latest Analyst Ratings for Becton, Dickinson
Via Benzinga
Becton, Dickinson's Debt Overview
Via Benzinga
Becton, Dickinson Shares Dip Despite Q2 Earnings Beat - Here's The Deatils
Becton, Dickinson, and Company (NYSE: BDX) posted profits of $460 million, equivalent to $2.86 per share,  
Via Benzinga
Becton Dickinson 'Capable Of Sustaining A Breakout', Analyst Upgrades Stock With 20% Upside Potential
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2023
Via Benzinga
(BDX) - Analyzing Becton, Dickinson's Short Interest
Via Benzinga
Looking Into Becton's Return On Capital Employed
Via Benzinga
What 6 Analyst Ratings Have To Say About Becton, Dickinson
Via Benzinga
Dividend Income Update March 2023
It’s dividend income update time. One of my favorite times of the month as I get to review my previous month of passive income received from my dividend income portfolio. 
Via Talk Markets
7 Dividend Aristocrats to Buy for Consistent Income Growth
The dividend aristocrats each provide consistent income growth over the long-term that those seeking passive income can rely on. 
Via InvestorPlace
3 Healthcare Spinoffs Worth a Look, But 1 Has the Best Long-Term Potential
These three spinoffs are already profitable. 
Via The Motley Fool
Healthcare Stocks With at Least 30 Years of Dividend Increases
Among the many industry sectors to invest in, healthcare can be one of the most stable, especially regarding the dividend yield. 
Via MarketBeat
A Bullish Sign Appears On Becton, Dickinson's Chart
Via Benzinga
3 Stocks To Buy For Consistent Dividend Growth
One way to avoid some of the volatility in the stock market is to buy old companies that have a long history of raising dividends. These are companies with iconic brands, lasting products, and... 
Via Talk Markets
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
By David Willey, Benzinga 
Via TheNewswire.com
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company? 
Via News Direct
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
The medical device and supply manufacturing industry is focused on the design and production of medical instruments and devices. 
Via Benzinga
Lucira Stock Jumps over 250% on FDA Approval, Beware Chapter 11
Lucira Health Inc. (NASDAQ: LHDX) shares spiked up 264% to close at $0.52 on a massive 278 million shares traded on the announcement of FDA approval for its 
Via MarketBeat
Topics Initial Public Offering
Exposures COVID-19 Product Safety Securities Market
The 7 Best Dividend Growth Stocks for Long-Term Investors
Although passive income is always useful under uncertain times, why not get capital gains through the best dividend growth stocks? 
Via InvestorPlace
Becton Dickinson Reports Cybersecurity Vulnerabilities For Alaris Infusion Monitoring Software
Becton Dickinson and Co (NYSE: BDX) issued a voluntary notification regarding cybersecurity vulnerabilities with its Alaris Infusion Central software. 
Via Benzinga
With COVID-19 Having Placed A Sharp Focus On Syringes, This Innovator Looks Back At A Year Of Successes Since Their 2022 IPO
Medical device company Sharps Technology Inc. (NASDAQ: STSS) is taking stock as it approaches one year since its initial public offering (IPO). Since its IPO, the company has taken major strides in... 
Via Benzinga
Why Embecta Stock Popped by Nearly 13% Today
Twin beats and raised guidance make for a good day on the market for the diabetes care specialist. 
Via The Motley Fool
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products
By David Willey, Benzinga 
Via TheNewswire.com
Topics Economy
Exposures Supply Chain
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products 
Via News Direct
Topics Economy
Exposures Supply Chain
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.